
|Articles|April 15, 2003
B&L wins extended range on laser; delays implant application
Rochester, NY-On the same day Bausch & Lomb celebrated FDA approval of a larger treatment range for its Technolas 217A excimer laser system, it said it would delay a year before asking the FDA to approve its Retisert drug-delivery implant.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
2
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
3
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
4
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
5


























